Merck KGaA to acquire chromatography business of JSR Life Sciences
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
The company will present new data from across over 20 cancer types and multiple treatment settings at European Society for Medical Oncology Congress 2025
The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation development, and Centrix Pharma Solutions in drug product development and clinical manufacturing
BIL also holds an option to increase its equity stake by an additional 15%
The state-of-the-art facility is a 450-bedded, multi-specialty tertiary care hospital,
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
CRISPR-based detection enables highly specific molecular recognition
The facility has been designed with a dual focus on efficiency and sustainability
Subscribe To Our Newsletter & Stay Updated